Florida Health Daily
SEE OTHER BRANDS

Your best source on healthcare and wellness news from Florida

Florida Health Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.

Press releases published on May 5, 2025

Healthy Workforce Institute Announces First Cohort of Certified Culture Change Leaders

Healthy Workforce Institute Announces First Cohort of Certified Culture Change Leaders

Trailblazing Group Completes the Healthy Workforce Culture Change Certification Program OLDSMAR, FL, UNITED STATES, May 5, 2025 /⁨EINPresswire.com⁩/ -- The Healthy Workforce Institute, a recognized leader in eradicating bullying and incivility in …

SABER College Now Enrolling for May 12 Start of Professional Nursing Program Amidst Growing Demand for RNs

SABER College Now Enrolling for May 12 Start of Professional Nursing Program Amidst Growing Demand for RNs

Career-ready training, small class sizes, and clinical experience prepare students to enter the nursing profession with confidence and purpose. MIAMI, FL, UNITED STATES, May 5, 2025 /⁨EINPresswire.com⁩/ -- As the demand for Registered Nurses grows across …

 Dr. Danay Rodriguez-Arritola Honored with 2025 Visionary Leader by Florida Nurses Association South Region

Dr. Danay Rodriguez-Arritola Honored with 2025 Visionary Leader by Florida Nurses Association South Region

Chief Nursing Officer Award by Florida Nurses Association South Region MIAMI, FL, UNITED STATES, May 5, 2025 /⁨EINPresswire.com⁩/ -- Dr. Danay Rodriguez-Arritola, Chief Nursing Officer at Larkin Community Hospital’s Palm Springs Campus, has been named the …

Touched by Type 1 Announces 24th Annual Conference — A National Gathering for the Type 1 Diabetes Community

Touched by Type 1 Announces 24th Annual Conference — A National Gathering for the Type 1 Diabetes Community

ORLANDO, FL, UNITED STATES, May 5, 2025 /⁨EINPresswire.com⁩/ -- The nationally recognized nonprofit Touched by Type 1 is proud to announce the 8th Annual Touched by Type 1 Conference, taking place on Saturday, September 20, 2025, at the Rosen Shingle Creek …

Dani Pettrey’s New Novel 'Two Seconds Too Late': A Gripping Tale of Faith, Suspense, and Supporting Veterans

Dani Pettrey’s New Novel 'Two Seconds Too Late': A Gripping Tale of Faith, Suspense, and Supporting Veterans

Dani Pettrey’s New Novel "Two Seconds Too Late": A Gripping Tale of Faith, Suspense, …

Kane Biotech Announces Closing of Private Placement Offering and Loan with Insiders of the Company

Kane Biotech Announces Closing of Private Placement Offering and Loan with Insiders of the Company

Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba, May 05, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company”, “Kane” or “Kane Biotech”) announces that today it has …

Sanuwave Will Host a Conference Call on May 9, 2025 at 8:30 AM (ET) to Present Q1 2025 Financial Results

Sanuwave Will Host a Conference Call on May 9, 2025 at 8:30 AM (ET) to Present Q1 2025 Financial Results

EDEN PRAIRIE, Minn., May 05, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (NASDAQ: SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live conference call on Friday, May 9, 2025, at 8: …

Harvard Bioscience Schedules First Quarter 2025 Earnings Conference Call for May 12, 2025 at 8:00 AM ET

Harvard Bioscience Schedules First Quarter 2025 Earnings Conference Call for May 12, 2025 at 8:00 AM ET

HOLLISTON, Mass., May 05, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended March 31, 2025, before the market opens on May 12, 2025, and will hold a conference call to discuss the …

LeMaitre to Present at the Bank of America Securities 2025 Healthcare Conference

LeMaitre to Present at the Bank of America Securities 2025 Healthcare Conference

BURLINGTON, Mass., May 05, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will present at the Bank of America Securities 2025 Healthcare Conference on Tuesday, May 13, 2024, at 5:00 PM PDT at …

DBV Technologies to Participate in the Citizens JMP Life Sciences Conference

DBV Technologies to Participate in the Citizens JMP Life Sciences Conference

Châtillon, France, May 5, 2025 DBV Technologies to Participate in the Citizens JMP Life Sciences Conference DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced …

DBV Technologies participera à la conférence Citizens JMP Life Sciences

DBV Technologies participera à la conférence Citizens JMP Life Sciences

Châtillon, France, le 5 mai (22 :30 CEST) 2025 DBV Technologies participera à la conférence Citizens JMP Life Sciences DBV Technologies (Euronext : DBV – ISIN : FR0010417345 – Nasdaq Stock Market : DBVT), société biopharmaceutique en phase clinique, …

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

MALVERN, Pa., May 05, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from …

Anaptys Announces First Quarter 2025 Financial Results and Provides Business Update

Anaptys Announces First Quarter 2025 Financial Results and Provides Business Update

Announced rosnilimab, a depleter and agonist targeting PD-1+ T cells, achieved positive results in Phase 2b rheumatoid arthritis (RA) trial; to present updated clinical and translational data in the first week of June Initial Phase 2 data for rosnilimab in …

Certara Reports First Quarter 2025 Financial Results

Certara Reports First Quarter 2025 Financial Results

RADNOR, Pa., May 05, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today reported its financial results for the first quarter of fiscal year 2025. First Quarter Highlights: Revenue was $106.0 …

SI-BONE, Inc. Reports Financial Results for the First Quarter 2025 and Updates 2025 Guidance

SI-BONE, Inc. Reports Financial Results for the First Quarter 2025 and Updates 2025 Guidance

First Quarter 2025 Financial Highlights (all comparisons are to the prior year period) Worldwide revenue of $47.3 million, representing growth of 24.9% U.S. revenue of $44.8 million, representing growth of 26.6% Gross margin of 79.7%, representing an …

Castle Biosciences Reports First Quarter 2025 Results

Castle Biosciences Reports First Quarter 2025 Results

Q1 2025 revenue increased 21% over Q1 2024 to $88 million Q1 2025 total test reports for our core revenue drivers (DecisionDx®-Melanoma, DecisionDx®-SCC, TissueCypher®) increased 33% over Q1 2024 Raising full-year 2025 revenue guidance to $287-297 million …

Context Therapeutics Announces Chief Medical Officer Transition

Context Therapeutics Announces Chief Medical Officer Transition

PHILADELPHIA, May 05, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging bispecific antibodies for solid tumors, today announced Dr. Karen Smith, …

Relay Therapeutics Reports First Quarter 2025 Financial Results and Corporate Updates

Relay Therapeutics Reports First Quarter 2025 Financial Results and Corporate Updates

Cash runway extended into 2029 Initiation of Phase 3 ReDiscover-2 trial on track for mid-2025 Initiated Phase 1 RLY-2608 vascular malformations clinical trial in Q1 Extended cash runway expected to fully fund the Company meaningfully past topline data for …

Castle Biosciences to Acquire Previse

Castle Biosciences to Acquire Previse

Expected to complement Castle’s current gastroenterology franchise Adds methylation technology developed at the Johns Hopkins University School of Medicine and additional technologies in development FRIENDSWOOD, Texas, May 05, 2025 (GLOBE NEWSWIRE) -- …

Mineralys Therapeutics to Announce First Quarter 2025 Financial Results and Host Conference Call on Monday, May 12, 2025

Mineralys Therapeutics to Announce First Quarter 2025 Financial Results and Host Conference Call on Monday, May 12, 2025

RADNOR, Pa., May 05, 2025 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease (CKD), obstructive sleep apnea (OSA) and …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service